Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Anne Roulston

3PUBLICATIONS
44CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jan 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Ezra Y Rosen, Timothy A Yap, Elisa Fontana

|Aug 07, 2024
Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy.

Victor Ng, Sonali Sinha, Ardijana Novaj

|Apr 21, 2022
CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition.

David Gallo, Jordan T F Young, Jimmy Fourtounis

Pageof 1

Frequent Collaborators

2 joint publications

Maria Koehler

2 joint publications

Ezra Y Rosen

1 joint publications

Ján Tkáč

1 joint publications

Daniel Durocher

1 joint publications

Victor Ng

1 joint publications

Sonali Sinha

1 joint publications

Ardijana Novaj

1 joint publications

Jennifer Ma

1 joint publications

Stephanie Lheureux

1 joint publications

Xin Pei

Frequent Collaborators

2 joint publications

Maria Koehler

2 joint publications

Ezra Y Rosen

1 joint publications

Ján Tkáč

1 joint publications

Daniel Durocher

Top Related Videos

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on : Oct 02, 2014

15.2K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on : Mar 07, 2025

308
Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on : Jan 07, 2013

18.3K
See more related videos

Top Related Videos

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on : Oct 02, 2014

15.2K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on : Mar 07, 2025

308
Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on : Jan 07, 2013

18.3K
See more related videos